Aflac Incorporated (BVMF:A1FL34)
| Market Cap | 318.23B +4.7% |
| Revenue (ttm) | 93.61B +13.6% |
| Net Income | 25.19B +99.5% |
| EPS | 48.55 +111.6% |
| Shares Out | n/a |
| PE Ratio | 12.63 |
| Forward PE | 16.84 |
| Dividend | 8.47 (1.35%) |
| Ex-Dividend Date | Aug 18, 2026 |
| Volume | n/a |
| Open | 629.37 |
| Previous Close | 629.37 |
| Day's Range | 629.37 - 629.37 |
| 52-Week Range | 562.50 - 658.61 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final ... [Read more]
Financial Performance
In 2025, Aflac's revenue was $17.16 billion, a decrease of -9.31% compared to the previous year's $18.93 billion. Earnings were $3.65 billion, a decrease of -33.01%.
Financial numbers in USD Financial StatementsNews
Aflac price target raised to $122 from $120 at Wells Fargo
Wells Fargo raised the firm’s price target on Aflac (AFL) to $122 from $120 and keeps an Equal Weight rating on the shares. Discussing the life insurance group, the firm…
Aflac initiated with an Underperform at Wolfe Research
Wolfe Research analyst Tracy Benguigui initiated coverage of Aflac (AFL) with an Underperform rating and $103 price target which represents 15% downside from current levels. The firm views the capital...
AFL Rebrands Network Services as AFL Integria™, Reflecting Expanded Vision for North American Connectivity
SPARTANBURG, S.C.--(BUSINESS WIRE)-- #WeAreAFL--AFL, an industry-leading manufacturer of fiber optic cables, connectivity, equipment and related services announces the launch of AFL Integria, a divisi...
Aflac along with renowned educator Ron Clark and DonorsChoose embark on project to teach children social-emotional skills
Company recently launched book, "Beyond Words," leads learning initiative designed to promote kindness and compassion through reading Aflac is expanding its support for children with cancer and blood ...
Aflac price target lowered to $116 from $117 at JPMorgan
JPMorgan lowered the firm’s price target on Aflac (AFL) to $116 from $117 and keeps a Neutral rating on the shares.
Aflac price target raised to $125 from $120 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Aflac (AFL) to $125 from $120 and keeps a Market Perform rating on the shares.
Aflac price target raised to $138 from $130 at Piper Sandler
Piper Sandler analyst Paul Newsome raised the firm’s price target on Aflac (AFL) to $138 from $130 and keeps an Overweight rating on the shares following quarterly results. The firm…
Aflac price target raised to $116 from $112 at Mizuho
Mizuho raised the firm’s price target on Aflac (AFL) to $116 from $112 and keeps an Underperform rating on the shares.
Aflac Earnings Call Transcript: Q2 2026
Q2 2026 saw strong adjusted EPS growth, robust capital returns, and solid segment performance in both Japan and the U.S. Asset repositioning and increased reinsurance capacity enhanced capital efficiency, while inflation and FX risks were well managed. Persistency and sales momentum remain positive.
Aflac Slides: Q2 2026
Aflac has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Aflac Earnings release: Q2 2026
Aflac released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Aflac Quarterly report: Q2 2026
Aflac has published its Q2 2026 quarterly earnings report on August 7, 2026.
Aflac price target raised to $99 from $98 at Barclays
Barclays analyst Alex Scott raised the firm’s price target on Aflac (AFL) to $99 from $98 and keeps an Underweight rating on the shares.
Insurer Aflac misses quarterly profit estimates on stronger dollar
Health and life insurer Aflac missed analysts' estimates for second-quarter profit on Thursday, hurt by a stronger dollar as well as weakness in its Japan unit.
Aflac reports Q2 adjusted EPS $1.75 consensus $1.76
Reports Q2 revenue $4.1B, consensus $4.24B. Commenting on the company’s results, Aflac (AFL) Incorporated Chairman and Chief Executive Officer Daniel P. Amos stated: “Aflac delivered solid earnings fo...
Aflac Incorporated Announces Second Quarter 2026 Results, Declares Third Quarter Dividend
COLUMBUS, Ga., Aug. 6, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its second quarter results.
Aflac management to meet with Piper Sandler
Meeting to be held on August 12-13 hosted by Piper Sandler.
76% of Gen Z and 63% of millennials turn to AI for first line of primary healthcare
Aflac Wellness Matters ® survey reveals wellness paradox: health confidence up, preventive care down Gen Z (76%) and millennials (63%) use AI for health supportbefore seeking professional medical care...
Aflac price target raised to $110 from $101 at TD Cowen
TD Cowen raised the firm’s price target on Aflac (AFL) to $110 from $101 and keeps a Hold rating on the shares. The firm upped targets in the life insurance…
Aflac price target raised to $117 from $108 at JPMorgan
JPMorgan raised the firm’s price target on Aflac (AFL) to $117 from $108 and keeps a Neutral rating on the shares. The firm adjusted targets in the life insurance group…
Josh Brown names top dividend stocks to own in 2026
As market volatility and shifting economic conditions test investor resolve, high-quality dividend payers remain a cornerstone for long-term growth and income. Josh Brown – the chief executive of Rith...
Aflac price target raised to $137 from $126 at BofA
BofA analyst Joshua Shanker raised the firm’s price target on Aflac (AFL) to $137 from $126 and keeps a Buy rating on the shares. Q2 featured several notable catastrophe events…
Aflac price target raised to $120 from $115 at Keefe Bruyette
Keefe Bruyette analyst Ryan Krueger raised the firm’s price target on Aflac (AFL) to $120 from $115 and keeps a Market Perform rating on the shares. The firm increased targets…
Aflac price target raised to $108 from $100 at Jefferies
Jefferies analyst Suneet Kamath raised the firm’s price target on Aflac (AFL) to $108 from $100 and keeps a Hold rating on the shares. U.S. life insurers saw mixed stock…
Aflac price target raised to $112 from $104 at Mizuho
Mizuho analyst Yaron Kinar raised the firm’s price target on Aflac (AFL) to $112 from $104 and keeps an Underperform rating on the shares.